Inspire Pharmaceuticals, Inc.

Beautifully engraved specimen certificate from the Inspire Pharmaceuticals, Inc. . This historic document was printed by the Banknote Corporation of America and has an ornate border around it with an underprint of the company's logo. This item has the printed signatures of the Company’s President/CEO and CBO/Secretary.

Inspire Pharmaceuticals, Inc. discovers and develops new drugs to treat diseases characterized by deficiencies in the body's innate defense mechanisms of mucosal hydration and mucociliary clearance, as well as other non-mucosal disorders. These mechanisms are the natural way that the body defends its mucosal surfaces against dust, pollutants, bacteria and viruses. Mucosal hydration involves the moistening of the body's mucosal surfaces, and mucociliary clearance involves a blanket-like movement of fluid and particles from the lungs and sinuses. Mucosal surfaces are tissues containing specialized cells that lubricate and protect surfaces of organs that are directly exposed to the outside environment, such as the lungs, eyes and sinuses.